351 related articles for article (PubMed ID: 31819518)
1. Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer.
Guo Y; Cao R; Zhang X; Huang L; Sun L; Zhao J; Ma J; Han C
Onco Targets Ther; 2019; 12():10343-10360. PubMed ID: 31819518
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK.
Rothschild SI
Cancers (Basel); 2015 May; 7(2):930-49. PubMed ID: 26018876
[TBL] [Abstract][Full Text] [Related]
3. Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations.
König D; Savic Prince S; Rothschild SI
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671873
[TBL] [Abstract][Full Text] [Related]
4. Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.
Califano R; Abidin A; Tariq NU; Economopoulou P; Metro G; Mountzios G
Cancer Treat Rev; 2015 May; 41(5):401-11. PubMed ID: 25842168
[TBL] [Abstract][Full Text] [Related]
5. Beyond
Gkolfinopoulos S; Mountzios G
Ann Transl Med; 2018 Apr; 6(8):142. PubMed ID: 29862231
[TBL] [Abstract][Full Text] [Related]
6. Emerging oncogenic fusions other than
Suda K; Mitsudomi T
Transl Lung Cancer Res; 2020 Dec; 9(6):2618-2628. PubMed ID: 33489822
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC.
Bansal P; Osman D; Gan GN; Simon GR; Boumber Y
Front Oncol; 2016; 6():112. PubMed ID: 27200298
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives.
Genova C; Rossi G; Tagliamento M; Rijavec E; Biello F; Cerbone L; Zullo L; Grossi F
Expert Rev Respir Med; 2020 Apr; 14(4):367-383. PubMed ID: 31917616
[No Abstract] [Full Text] [Related]
9. Targeted therapy for NSCLC with driver mutations.
Minuti G; D'Incecco A; Cappuzzo F
Expert Opin Biol Ther; 2013 Oct; 13(10):1401-12. PubMed ID: 23930754
[TBL] [Abstract][Full Text] [Related]
10. Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion.
Chu QS
Ther Adv Med Oncol; 2020; 12():1758835919895756. PubMed ID: 32047535
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic alterations in advanced NSCLC: a molecular super-highway.
Friedlaender A; Perol M; Banna GL; Parikh K; Addeo A
Biomark Res; 2024 Feb; 12(1):24. PubMed ID: 38347643
[TBL] [Abstract][Full Text] [Related]
12. Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.
Shea M; Costa DB; Rangachari D
Ther Adv Respir Dis; 2016 Apr; 10(2):113-29. PubMed ID: 26620497
[TBL] [Abstract][Full Text] [Related]
13. Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer.
Tartarone A; Lapadula V; Di Micco C; Rossi G; Ottanelli C; Marini A; Giorgione R; Ferrari K; Catalano M; Voltolini L; Mini E; Roviello G
Front Oncol; 2021; 11():632256. PubMed ID: 34094913
[TBL] [Abstract][Full Text] [Related]
14. Beyond
Farago AF; Azzoli CG
Transl Lung Cancer Res; 2017 Oct; 6(5):550-559. PubMed ID: 29114471
[TBL] [Abstract][Full Text] [Related]
15. Emerging protein kinase inhibitors for non-small cell lung cancer.
Liu SV; Subramaniam D; Cyriac GC; Abdul-Khalek FJ; Giaccone G
Expert Opin Emerg Drugs; 2014 Mar; 19(1):51-65. PubMed ID: 24354593
[TBL] [Abstract][Full Text] [Related]
16. Targeting oncogenic drivers in lung cancer: Recent progress, current challenges and future opportunities.
Yoda S; Dagogo-Jack I; Hata AN
Pharmacol Ther; 2019 Jan; 193():20-30. PubMed ID: 30121320
[TBL] [Abstract][Full Text] [Related]
17. Targeted Therapies for Lung Cancer.
Stinchcombe TE
Cancer Treat Res; 2016; 170():165-82. PubMed ID: 27535394
[TBL] [Abstract][Full Text] [Related]
18. New Targets in Non-Small Cell Lung Cancer.
Park SJ; More S; Murtuza A; Woodward BD; Husain H
Hematol Oncol Clin North Am; 2017 Feb; 31(1):113-129. PubMed ID: 27912827
[TBL] [Abstract][Full Text] [Related]
19. Non-Small-Cell Lung Cancer: New Rare Targets-New Targeted Therapies-State of The Art and Future Directions.
Stencel K; Chmielewska I; Milanowski J; Ramlau R
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921237
[TBL] [Abstract][Full Text] [Related]
20. NSCLC and HER2: between lights and shadows.
Ricciardi GR; Russo A; Franchina T; Ferraro G; Zanghì M; Picone A; Scimone A; Adamo V
J Thorac Oncol; 2014 Dec; 9(12):1750-62. PubMed ID: 25247338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]